Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Cogs-Excluding-Depreciation-and-Amortization" stands at 174.66 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 06/30/2018.
Eisai Co. Ltd.'s second quarter result of 45.52 Billion JPY for the item "Cogs Excluding Depreciation and Amortization" represents an increase of 6.86 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 45.52 Billion JPY for the item "Cogs Excluding Depreciation and Amortization" represents an increase of 7.09 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 174.66 Billion JPY for the item "Cogs Excluding Depreciation and Amortization" represents an increase of 1.75 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 27.14 percent compared to the value the year prior.
The 1 year change in percent is 27.14.
The 3 year change in percent is 17.45.
The 5 year change in percent is 27.16.
The 10 year change in percent is 10.17.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cogs Excluding Depreciation and Amortization | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cogs Excluding Depreciation and Amortization | 486,508,953,600.00 |
![]() | AbbVie Inc - Cogs Excluding Depreciation and Amortization | 399,570,305,024.00 |
![]() | Roche Holding AG - Cogs Excluding Depreciation and Amortization | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cogs Excluding Depreciation and Amortization | 280,205,508,085.11 |